We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRX
5926
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$51K ﹤0.01%
686
+131
+24% +$11.7K
RARX
5927
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$51K ﹤0.01%
5,171
-43,582
-89% -$301K
PETX
5928
DELISTED
Aratana Therapeutics, Inc.
PETX
$51K ﹤0.01%
12,012
+2,961
+33% +$14.9K
REIS
5929
DELISTED
Reis, Inc.
REIS
$51K ﹤0.01%
2,375
+2,359
+14,744% +$50.3K
BLK icon
5930
PUT
Blackrock
BLK
$176B
$50K ﹤0.01%
100
-100
-50% -$52.8K
DXD icon
5931
ProShares UltraShort Dow 30
DXD
$38.3M
$50K ﹤0.01%
290
+90
+45% +$15.2K
EBTC
5932
DELISTED
Enterprise Bancorp
EBTC
$50K ﹤0.01%
1,230
+737
+149% +$28.1K
FONR
5933
DELISTED
Fonar
FONR
$50K ﹤0.01%
1,891
+1,751
+1,251% +$48.8K
KOPN icon
5934
Kopin
KOPN
$776M
$50K ﹤0.01%
17,739
+14,693
+482% +$48.5K
MTR
5935
Mesa Royalty Trust
MTR
$5.29M
$50K ﹤0.01%
3,421
+2,490
+267% +$37.9K
NSSC icon
5936
Napco Security Technologies
NSSC
$1.47B
$50K ﹤0.01%
6,816
-718
-10% -$4.24K
PKBK icon
5937
Parke Bancorp
PKBK
$398M
$50K ﹤0.01%
2,294
+448
+24% +$8.71K
RIGL icon
5938
Rigel Pharmaceuticals
RIGL
$747M
$50K ﹤0.01%
1,765
-40,576
-96% -$1.44M
UTSL icon
5939
Direxion Daily Utilities Bull 3X ETF
UTSL
$35.3M
$50K ﹤0.01%
1,957
+396
+25% +$9.21K
TECX
5940
Tectonic Therapeutic
TECX
$601M
$50K ﹤0.01%
+146
New +$52.7K
CWBR
5941
DELISTED
CohBar, Inc. Common Stock
CWBR
$50K ﹤0.01%
253
+210
+488% +$40.7K
ZYNE
5942
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$50K ﹤0.01%
5,208
-2,225
-30% -$22.8K
SCTO
5943
DELISTED
Global X JPMorgan US Sector Rotator Index ETF
SCTO
$50K ﹤0.01%
1,890
-100
-5% -$2.64K
AMPH icon
5944
Amphastar Pharmaceuticals
AMPH
$980M
$49K ﹤0.01%
3,235
-3,712
-53% -$64.9K
CNXN icon
5945
PC Connection
CNXN
$2.17B
$49K ﹤0.01%
+1,473
New +$43.1K
DIEM icon
5946
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$74.6M
$49K ﹤0.01%
1,636
+1,301
+388% +$41.7K
FLEE icon
5947
Franklin FTSE Europe ETF
FLEE
$121M
$49K ﹤0.01%
2,020
-1,291
-39% -$32.8K
GRP.U
5948
DELISTED
Granite Real Estate Investment Trust
GRP.U
$49K ﹤0.01%
1,209
+290
+32% +$11.7K
HCKT icon
5949
Hackett Group
HCKT
$287M
$49K ﹤0.01%
3,062
+2,662
+666% +$43.3K
MRSH
5950
PUT
Marsh
MRSH
$91.8B
$49K ﹤0.01%
600
-800
-57% -$65.3K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.